12/18/2019 8:09:24 AM
Soliton Announces Completion Of Safety Testing At SGS To Support FDA Filing For Second Generation Device
12/10/2019 8:02:04 AM
Soliton Appoints Mary Stoll As Senior Director Of Clinical Development
11/21/2019 8:08:34 AM
Soliton And Emphysys Enter Into A 3-year Development Deal
11/5/2019 9:04:19 AM
Soliton Says Pivotal Cellulite Trial Has Been Completed
10/25/2019 8:11:32 AM
Soliton Reports Positive Interim Trial Results With 27% Reduction In Scar Volume From Single Non Invasive Treatment
10/10/2019 8:37:24 AM
Soliton Announces $6.25 Mln Private Placement
8/14/2019 8:22:47 AM
Soliton Treats First Patients In Pivotal Cellulite Trial
8/12/2019 8:07:26 AM
Soliton Says Patient Recruitment Begins For Pivotal Cellulite Trial
8/6/2019 8:04:51 AM
Soliton Closes Site Enrollment And Conducts Initial Site Training To Start Pivotal Cellulite Trial
7/15/2019 8:07:39 AM
Soliton Reports Addl Positive Data From Its Proof Of Concept Clinical Trial For The Reduction Of Cellulite
7/2/2019 8:14:23 AM
Soliton Announces Filing Of Form S-1 Registering The Shares Issued In Private Placement At $14/Unit